Category: Pα+ - Page 7 - Psychedelic Alpha

Read more about the article Pα+ Psychedelic Bulletin #168: California’s Psychedelic Research Bottleneck Ends Today; Neşe Devenot’s Letter to the Editor; Oregon’s Psilocybin Services a Year In; Disability and Psychedelics

Pα+ Psychedelic Bulletin #168: California’s Psychedelic Research Bottleneck Ends Today; Neşe Devenot’s Letter to the Editor; Oregon’s Psilocybin Services a Year In; Disability and Psychedelics

Post published:July 19, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Post published:July 16, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated Workshop Discusses Ketamine; EMA Associates Publish Recap of Psychedelics Workshop

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated Workshop Discusses Ketamine; EMA Associates Publish Recap of Psychedelics Workshop

Post published:July 12, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Post published:July 9, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA; Drug Devs Clarify Trial Design In Wake of AdComm; Mini Interview: Joshua Ismin, Psylo

Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA; Drug Devs Clarify Trial Design In Wake of AdComm; Mini Interview: Joshua Ismin, Psylo

Post published:July 5, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral Ketamine for Depression Study; UN Weighs In on Psychedelics; Another CA Psychedelics Bill Fails

Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral Ketamine for Depression Study; UN Weighs In on Psychedelics; Another CA Psychedelics Bill Fails

Post published:June 28, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

Post published:June 21, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Post published:June 14, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote

Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote

Post published:June 11, 2024
Post category:Analysis News Pα+

Read more about the article ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Post published:May 31, 2024
Post category:Analysis News Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.